warnings
WARNINGS If inflammation persists or worsens or if new symptoms occur, the patient should be carefully re-evaluated because these could be signs of a more serious condition.
FDA label 50c79f13-58df-476a-afef-a9c27cfe9055
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 68111437-b4cd-469f-8547-a2ce022842da
- SPL ID
- 50c79f13-58df-476a-afef-a9c27cfe9055
- Version
- 5
- Effective date
- 2016-07-19
- Source export date
- 2026-09-28
- Source partition
- 13
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:30:43
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 50c79f13-58df-476a-afef-a9c27cfe9055 | id | |
| spl set id | 68111437-b4cd-469f-8547-a2ce022842da | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS In rare cases, patients with hypersensitivity to botanicals of the Asteraceae/Compositae family may experience an allergic reaction after administration of Perio GS including anaphylactic reaction. Perio GS ingredients of the Asteraceae/Compositae family are: Echinacea purpurea (purple cone flower) No hypersensitivity reactions have been reported with Perio GS, but caution should be taken by those patients with hypersensitivity to the Compositae family. Some patients in clinical studies have reported a bitter or bad taste. This effect is temporary and resolves upon cessation of treatment.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.